Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 507

1.

Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.

Ge X, Li CR, Yang J, Wang GB.

Scand J Immunol. 2013 May;77(5):389-97. doi: 10.1111/sji.12022.

2.

The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease.

Jia S, Li C, Wang G, Yang J, Zu Y.

Clin Exp Immunol. 2010 Oct;162(1):131-7. doi: 10.1111/j.1365-2249.2010.04236.x. Epub 2010 Aug 16.

3.
4.

Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.

Matusali G, Tchidjou HK, Pontrelli G, Bernardi S, D'Ettorre G, Vullo V, Buonomini AR, Andreoni M, Santoni A, Cerboni C, Doria M.

FASEB J. 2013 Jun;27(6):2440-50. doi: 10.1096/fj.12-223057. Epub 2013 Feb 8.

PMID:
23395909
5.

NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.

Dejaco C, Duftner C, Al-Massad J, Wagner AD, Park JK, Fessler J, Aigelsreiter A, Hafner F, Vega S, Sterlacci W, Grubeck-Loebenstein B, Tzankov A, Ness T, Boiardi L, Salvarani C, Schirmer M.

Ann Rheum Dis. 2013 Nov;72(11):1852-9. doi: 10.1136/annrheumdis-2012-201660. Epub 2013 Feb 15.

PMID:
23417963
6.

Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.

Ikeda K, Yamaguchi K, Tanaka T, Mizuno Y, Hijikata A, Ohara O, Takada H, Kusuhara K, Hara T.

Clin Exp Immunol. 2010 May;160(2):246-55. doi: 10.1111/j.1365-2249.2009.04073.x. Epub 2009 Dec 15.

7.

Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.

Schwinn N, Vokhminova D, Sucker A, Textor S, Striegel S, Moll I, Nausch N, Tuettenberg J, Steinle A, Cerwenka A, Schadendorf D, Paschen A.

Int J Cancer. 2009 Apr 1;124(7):1594-604. doi: 10.1002/ijc.24098.

8.

Natural Killer Group 2A Expressed on Both Peripheral CD3-CD56+NK Cells and CD3+CD8+T Cells Plays a Pivotal Negative Regulatory Role in the Progression of Hepatitis B Virus-Related Acute-on-Chronic Liver Failure.

Yi RT, Niu YH, Liu HL, Zhang TY, Yang YC, Zhang Y, Yin DL, Chen TY, Zhao YR.

J Interferon Cytokine Res. 2016 Dec;36(12):689-697. Epub 2016 Nov 9.

PMID:
27828717
9.

Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.

Santin AD, Bellone S, Palmieri M, Bossini B, Dunn D, Roman JJ, Pecorelli S, Cannon M, Parham GP.

Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1345-55.

PMID:
12459356
10.

Differential effects of interleukin-12 and interleukin-15 on expansion of NK cell receptor-expressing CD8+ T cells.

Sugita J, Tanaka J, Yasumoto A, Shiratori S, Wakasa K, Kikuchi M, Shigematsu A, Kondo T, Asaka M, Imamura M.

Ann Hematol. 2010 Feb;89(2):115-20. doi: 10.1007/s00277-009-0780-0. Epub 2009 Jul 4.

PMID:
19578849
11.
12.

Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus.

Li WX, Pan HF, Hu JL, Wang CZ, Zhang N, Li J, Li XP, Xu JH, Ye DQ.

Clin Rheumatol. 2010 Mar;29(3):315-23. doi: 10.1007/s10067-009-1322-9. Epub 2009 Dec 10.

PMID:
20012119
13.

Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.

Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR.

J Immunol. 2008 Nov 15;181(10):6711-9.

14.

[The role of activation of toll-like receptors in immunological pathogenesis of Kawasaki disease].

Wang GB, Li CR, Zu Y, Yuan XW.

Zhonghua Er Ke Za Zhi. 2006 May;44(5):333-6. Chinese.

PMID:
16780707
15.

Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.

von Lilienfeld-Toal M, Frank S, Leyendecker C, Feyler S, Jarmin S, Morgan R, Glasmacher A, Märten A, Schmidt-Wolf IG, Brossart P, Cook G.

Cancer Immunol Immunother. 2010 Jun;59(6):829-39. doi: 10.1007/s00262-009-0807-3. Epub 2009 Dec 19.

PMID:
20024547
16.

IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion.

Correia MP, Costa AV, Uhrberg M, Cardoso EM, Arosa FA.

Immunobiology. 2011 May;216(5):604-12. doi: 10.1016/j.imbio.2010.09.012. Epub 2010 Sep 24.

PMID:
20956026
17.

Expression of NK cell and monocyte receptors in critically ill patients--potential biomarkers of sepsis.

Kjaergaard AG, Nielsen JS, Tønnesen E, Krog J.

Scand J Immunol. 2015 Apr;81(4):249-58. doi: 10.1111/sji.12272.

18.

Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.

Giordani L, Quaranta MG, Marchesi A, Straface E, Pietraforte D, Villani A, Malorni W, Del Principe D, Viora M.

Clin Exp Immunol. 2011 Mar;163(3):346-53. doi: 10.1111/j.1365-2249.2010.04297.x. Epub 2010 Dec 22.

19.

Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.

Liu Z, Yang L, Cui Y, Wang X, Guo C, Huang Z, Kan Q, Liu Z, Liu Y.

Inflamm Bowel Dis. 2009 Aug;15(8):1133-44. doi: 10.1002/ibd.20923.

PMID:
19322899
20.

Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.

Gonzalez VD, Falconer K, Björkström NK, Blom KG, Weiland O, Ljunggren HG, Alaeus A, Sandberg JK.

J Immunol. 2009 Nov 15;183(10):6612-8. doi: 10.4049/jimmunol.0901437. Epub 2009 Oct 21.

Supplemental Content

Support Center